1. Home
  2. KNSA vs UFPT Comparison

KNSA vs UFPT Comparison

Compare KNSA & UFPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • UFPT
  • Stock Information
  • Founded
  • KNSA 2015
  • UFPT 1963
  • Country
  • KNSA United Kingdom
  • UFPT United States
  • Employees
  • KNSA N/A
  • UFPT N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • UFPT Medical/Dental Instruments
  • Sector
  • KNSA Health Care
  • UFPT Health Care
  • Exchange
  • KNSA Nasdaq
  • UFPT Nasdaq
  • Market Cap
  • KNSA 1.9B
  • UFPT 1.7B
  • IPO Year
  • KNSA 2018
  • UFPT 1993
  • Fundamental
  • Price
  • KNSA $33.28
  • UFPT $224.00
  • Analyst Decision
  • KNSA Strong Buy
  • UFPT Buy
  • Analyst Count
  • KNSA 6
  • UFPT 2
  • Target Price
  • KNSA $40.83
  • UFPT $289.00
  • AVG Volume (30 Days)
  • KNSA 711.9K
  • UFPT 111.2K
  • Earning Date
  • KNSA 07-29-2025
  • UFPT 08-04-2025
  • Dividend Yield
  • KNSA N/A
  • UFPT N/A
  • EPS Growth
  • KNSA N/A
  • UFPT 34.62
  • EPS
  • KNSA 0.07
  • UFPT 8.62
  • Revenue
  • KNSA $529,332,000.00
  • UFPT $588,559,000.00
  • Revenue This Year
  • KNSA $37.21
  • UFPT $22.16
  • Revenue Next Year
  • KNSA $6.10
  • UFPT $5.60
  • P/E Ratio
  • KNSA $504.35
  • UFPT $26.06
  • Revenue Growth
  • KNSA 56.18
  • UFPT 40.98
  • 52 Week Low
  • KNSA $17.82
  • UFPT $178.26
  • 52 Week High
  • KNSA $33.98
  • UFPT $366.41
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 65.73
  • UFPT 47.47
  • Support Level
  • KNSA $31.78
  • UFPT $196.83
  • Resistance Level
  • KNSA $33.66
  • UFPT $230.02
  • Average True Range (ATR)
  • KNSA 1.26
  • UFPT 12.69
  • MACD
  • KNSA 0.24
  • UFPT -0.33
  • Stochastic Oscillator
  • KNSA 90.63
  • UFPT 43.08

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About UFPT UFP Technologies Inc.

UFP Technologies Inc is a designer and custom manufacturer of components, subassemblies, products, and packaging utilizing specialized foams, films, and plastics for the medical market. The company manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.

Share on Social Networks: